Current Pharmaceutical Biotechnology
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 14
Author(s): Filippo Rossi
Affiliation:
Export Options
About this article
Cite this article as:
Rossi Filippo , Meet Our Editorial Board Member, Current Pharmaceutical Biotechnology 2017; 18 (14) . https://dx.doi.org/10.2174/138920101814180420164634
DOI https://dx.doi.org/10.2174/138920101814180420164634 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
19
2
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mesenchymal Stem Cells: A Potent Cell Source for COVID-19
Coronaviruses Targeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain
Current Neuropharmacology Molecular Mechanisms Mediating Nociceptin/Orphanin FQ Receptor Signaling, Desensitization and Internalization
Current Molecular Pharmacology Intrathecal Enzyme Replacement Therapy for Mucopolysaccharidosis I: Translating Success in Animal Models to Patients
Current Pharmaceutical Biotechnology The Oxygen Therapy
Current Medicinal Chemistry From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry The Coronin Family and Human Disease
Current Protein & Peptide Science A Novel Unified Ab Initio and Template-Based Approach to GPCR Modeling: Case of EDG-LPA Receptors.
Current Bioinformatics Nanotechnology and Alzheimer's Disease: What has been Done and What to Do'
Current Medicinal Chemistry Mesenchymal Stem Cells for Treatment of CNS Injury
Current Neuropharmacology Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer
Anti-Cancer Agents in Medicinal Chemistry Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
Current Pharmaceutical Design New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Regulation of P2X3 Receptor Structure and Function
CNS & Neurological Disorders - Drug Targets The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Melatonin Synthetic Analogs as Nitric Oxide Synthase Inhibitors
Mini-Reviews in Medicinal Chemistry Current Trend and Pro-survival Approaches for Augmenting Stem Cell Viability
Current Pharmaceutical Biotechnology Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design